(Q37611853)

21 August 2017

1 reference

title

Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus (English)

1 reference

21 August 2017

1 reference

1 reference

Fu-Sheng Wang

1

1 reference

21 August 2017

Zheng Zhang

series ordinal

2

1 reference

21 August 2017

publication date

1 October 2009

1 reference

Expert Review of Gastroenterology & Hepatology

21 August 2017

published in

1 reference

21 August 2017

volume

3

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

499-512

1 reference

Hepatitis B virus infection--natural history and clinical consequences

21 August 2017

cites work

1 reference

21 January 2018

1 reference

Hepatitis B Virus Infection

21 January 2018

1 reference

A "NEW" ANTIGEN IN LEUKEMIA SERA

21 January 2018

1 reference

Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges

21 January 2018

1 reference

Immunopathogenesis of hepatitis B virus infection

21 January 2018

1 reference

Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.

21 January 2018

1 reference

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

Immunology of hepatitis B infection

21 January 2018

1 reference

21 January 2018

1 reference

Dynamics of hepatitis B virus clearance in chimpanzees

21 January 2018

1 reference

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

21 January 2018

1 reference

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection

21 January 2018

1 reference

Innate immune response and hepatic inflammation

21 January 2018

1 reference

Innate sensing of viruses by toll-like receptors

21 January 2018

1 reference

Genomic analysis of the host response to hepatitis B virus infection

21 January 2018

1 reference

Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice

21 January 2018

1 reference

Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells

21 January 2018

1 reference

Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

21 January 2018

1 reference

Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells

21 January 2018

1 reference

Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein

21 January 2018

1 reference

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

21 January 2018

1 reference

Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures

21 January 2018

1 reference

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

The liver as an immunological organ

21 January 2018

1 reference

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection

21 January 2018

1 reference

Long-lasting memory T cell responses following self-limited acute hepatitis B

21 January 2018

1 reference

21 January 2018

1 reference

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

21 January 2018

1 reference

Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection

21 January 2018

1 reference

Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C

21 January 2018

1 reference

Memory CD8 T-cell differentiation during viral infection

21 January 2018

1 reference

Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.

21 January 2018

1 reference

Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients

21 January 2018

1 reference

Oscillating CD8(+) T cell effector functions after antigen recognition in the liver.

21 January 2018

1 reference

The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

21 January 2018

1 reference

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

21 January 2018

1 reference

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage

21 January 2018

1 reference

Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression

21 January 2018

1 reference

Hepatic T cells and liver tolerance

21 January 2018

1 reference

Dendritic cells and immune regulation in the liver

21 January 2018

1 reference

Interleukin-10 secretion differentiates dendritic cells from human liver and skin

21 January 2018

1 reference

Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases

21 January 2018

1 reference

Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.

21 January 2018

1 reference

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

21 January 2018

1 reference

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection

21 January 2018

1 reference

Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection

21 January 2018

1 reference

Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection

21 January 2018

1 reference

Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans

21 January 2018

1 reference

Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.

21 January 2018

1 reference

Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

21 January 2018

1 reference

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection

21 January 2018

1 reference

Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response

21 January 2018

1 reference

The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection.

21 January 2018

1 reference

Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection

21 January 2018

1 reference

Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.

21 January 2018

1 reference

Autoimmune diseases of the liver, autoimmune hepatitis and primary biliary cirrhosis: Unfinished business.

21 January 2018

1 reference

The enigmatic X gene of hepatitis B virus

21 January 2018

1 reference

Hepatitis B virus X protein modulates apoptosis in primary rat hepatocytes by regulating both NF-kappaB and the mitochondrial permeability transition pore

21 January 2018

1 reference

Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential

21 January 2018

1 reference

Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection

21 January 2018

1 reference

Interaction of the hepatitis B core antigen and the innate immune system

21 January 2018

1 reference

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

21 January 2018

1 reference

Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection

21 January 2018

1 reference

Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance

21 January 2018

1 reference

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

21 January 2018

1 reference

Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.

21 January 2018

1 reference

A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients

21 January 2018

1 reference

The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope

21 January 2018

1 reference

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus.

21 January 2018

1 reference

Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection

21 January 2018

1 reference

Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment

21 January 2018

1 reference

Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.

21 January 2018

1 reference

Strategies for the management of hepatocellular carcinoma

21 January 2018

1 reference

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

Benefits and risks of interferon therapy for hepatitis B.

21 January 2018

1 reference

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

21 January 2018

1 reference

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

21 January 2018

1 reference

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

21 January 2018

1 reference

Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.

21 January 2018

1 reference

Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection

21 January 2018

1 reference

Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B.

21 January 2018

1 reference

Monitoring during and after antiviral therapy for hepatitis B.

21 January 2018

1 reference

Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells

21 January 2018

1 reference

The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis

21 January 2018

1 reference

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.

21 January 2018

1 reference

Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model

21 January 2018

1 reference

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

21 January 2018

1 reference

Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.09.50

1 reference

21 August 2017

1 reference